A Pilot Randomised Control Trial of an Online Acceptance and Commitment Therapy (ACT) Resilience Training Program for People with Multiple Sclerosis
Sclerosis · 2023
DOI: 10.3390/sclerosis1010005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sclerosis, 2023. Verfasst von Kenneth I. Pakenham und 1 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biogen Australia Pty Ltd..
Abstract (Originalsprache)
Background
This pilot study explored the effectiveness and feasibility of an online version of a group acceptance and commitment therapy (ACT) resilience training intervention for people with multiple sclerosis (PwMS), called e-READY for Multiple Sclerosis (MS).
Methods
Fifty-six PwMS were randomized to intervention (n = 31) or waitlist control (WLC) (n = 25). The primary outcome, resilience, and secondary outcomes (quality of life (QoL), distress, psychological flexibility) were assessed at pre- and post-intervention and 12-week follow-up.
Results
Intervention participants reported greater pre- to post-intervention improvements in anxiety (d = 0.56) and stress (d = 0.62) than WLC. Gains were maintained at follow-up. Confidence intervals revealed a trend for the intervention group to report greater improvements than WLC across all outcomes. Reliable Change Index data showed that, compared to WLC, there were trends for more intervention participants to evidence clinically significant improvements in physical health QoL. Recruitment response was weak, intervention retention was good, adherence to program progression guidelines was satisfactory, program usability satisfaction was high, and study protocol attrition at post-intervention and follow-up was low and high, respectively. Most participants viewed the intervention as enjoyable, helpful, and resilience-building, and would recommend it to other PwMS. Qualitative feedback validated the usefulness of intervention tools and digital delivery mode and bolstered resilience through improved ACT-related skills.
Conclusions
Effectiveness and feasibility results from this proof-of-concept study provide preliminary support for the e-READY for MS program.
Förderung
- Biogen Australia Pty Ltd.
Zitieren
APA
Pakenham, K. I., & Landi, G. (2023). A Pilot Randomised Control Trial of an Online Acceptance and Commitment Therapy (ACT) Resilience Training Program for People with Multiple Sclerosis. Sclerosis. https://doi.org/10.3390/sclerosis1010005
Vancouver
Pakenham KI, Landi G. A Pilot Randomised Control Trial of an Online Acceptance and Commitment Therapy (ACT) Resilience Training Program for People with Multiple Sclerosis. Sclerosis. 2023. doi:10.3390/sclerosis1010005
BibTeX
@article{Pakenham2023,
author = {Pakenham, Kenneth I. and Landi, Giulia},
title = {A Pilot Randomised Control Trial of an Online Acceptance and Commitment Therapy (ACT) Resilience Training Program for People with Multiple Sclerosis},
journal = {Sclerosis},
year = {2023},
doi = {10.3390/sclerosis1010005}
}
EUVIMED